Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Black Diamond Therapeutics, Inc. (BDTX) had Weighted-Average Shares Outstanding (Diluted) of 57.37M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-9.90M |
|
-- |
|
-- |
|
$12.06M |
|
$-12.06M |
|
$2.15M |
|
$-9.90M |
|
$-9.90M |
|
$-9.90M |
|
$-9.90M |
|
$-9.90M |
|
$-9.90M |
|
$-12.06M |
|
$-12.03M |
|
57.37M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
57.37M |
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$115.39M |
|
$0.31M |
|
$9.63M |
|
$125.03M |
|
$15.84M |
|
-- |
|
$13.10M |
|
$28.94M |
|
$96.09M |
|
$96.09M |
|
$96.09M |
|
57.45M |
|
| Cash Flow Statement Financials | |
$-18.20M |
|
$16.38M |
|
$0.03M |
|
$21.82M |
|
$20.03M |
|
$-1.79M |
|
$2.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.31% |
|
-10.31% |
|
-7.92% |
|
-10.31% |
|
$1.67 |
|
$-0.32 |
|
$-0.32 |
|